Estée Lauder Earnings Beat, Raises Outlook, Expands Job Cuts

Estée Lauder earnings beat led management to raise FY2026 EPS to $2.35–$2.45, with China/Europe strength and PRGP margin gains supporting investor demand.

May 01, 2026·2 min read
View all news articles
Flat vector of a beauty-product storefront contracting to show Estée Lauder earnings focus on margin recovery and job cuts.

KEY TAKEAWAYS

  • Reported Q3 adjusted EPS beat and raised FY2026 adjusted EPS guidance to $2.35–$2.45.
  • PRGP execution widened adjusted operating margin to 15.0% and drove gross margin to 76.4%.
  • Expanded restructuring to 9,000–10,000 net role reductions and raised annual gross-benefit target to $1.0–$1.2 billion.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Estée Lauder Companies Inc. reported a fiscal third-quarter earnings beat on May 1, 2026, and raised its full-year outlook after stronger sales in China and Europe and margin gains from its Profit Recovery and Growth Plan (PRGP). The company also expanded its restructuring to reduce more roles.

Quarter Results and Outlook

For the quarter ended March 31, 2026, Estée Lauder reported net sales of $3.7 billion, up 5% year over year, with organic net sales rising 2%. Adjusted diluted earnings per share (EPS) reached $0.91, surpassing the consensus range of $0.66 to $0.67. Reported diluted EPS was $0.24, reflecting $127 million in restructuring charges and an $84 million securities-class-action loss contingency. Operating cash flow for the nine months ended March 31 rose 71% to $1.2 billion.

Adjusted operating margin expanded 360 basis points to 15.0%, while gross margin improved 140 basis points to 76.4%. Management attributed these gains to effective execution of the PRGP. Mainland China led regional performance with mid-single-digit net sales growth and outperformance of the prestige-beauty category, helping Estée Lauder gain share during key shopping periods.

The company raised its full-year FY2026 guidance to about 3% organic net sales growth and adjusted EPS of $2.35 to $2.45. It also issued preliminary FY2027 targets calling for 3% to 5% organic net sales growth and an adjusted operating margin between 12.5% and 13.0%.

Restructuring Expansion and Impact

Estée Lauder expanded its restructuring target to 9,000 to 10,000 net role reductions, up from a prior range of 5,800 to 7,000. More than 70% of the additional cuts will focus on point-of-sale staffing at “select unproductive doors” in department-store and freestanding channels.

Through the quarter, the company recognized $1.1 billion in cumulative restructuring charges and now expects total charges to reach $1.5 billion to $1.7 billion. It raised the program’s annual gross-benefits target to $1.0 billion to $1.2 billion. Management framed these actions under its One ELC and One Operating Ecosystem initiatives as key drivers of margin recovery and operating-expense reductions.

"Our third quarter results extend strong year-to-date performance, driven by Beauty Reimagined," said Stéphane de La Faverie, president and CEO.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Read other top news stories

Pentagon AI Contracts With Seven Tech Firms

Pentagon AI Contracts With Seven Tech Firms

Pentagon AI contracts give seven firms classified access, accelerating defense AI adoption and shifting vendor positions; no values disclosed.

Chevron Q1 2026 Earnings Beat on Upstream Strength

Chevron Q1 2026 Earnings Beat on Upstream Strength

Chevron Q1 2026 earnings beat as higher oil prices and upstream strength offset legal and currency charges; buyback guidance held, aiding repurchase flows.

Ares Q1 2026 Results Show Record Fundraising

Ares Q1 2026 Results Show Record Fundraising

Ares Q1 2026 results show record $30.0 billion fundraising and revenue growth, signaling robust institutional demand and easing private credit concerns.

ExxonMobil Q1 2026 Earnings Beat, Shares Slip

ExxonMobil Q1 2026 Earnings Beat, Shares Slip

ExxonMobil Q1 2026 earnings beat on adjusted measures but GAAP profit fell sharply after Iran disruptions and derivative timing, prompting share weakness.

Berkshire Hathaway Annual Meeting: Abel's Debut

Berkshire Hathaway Annual Meeting: Abel's Debut

Berkshire Hathaway annual meeting will test Greg Abel's debut as CEO and could shift investor sentiment and positioning after Buffett's exit.

Moderna Q1 2026 Results Show Vaccine Sales Lift

Moderna Q1 2026 Results Show Vaccine Sales Lift

Moderna Q1 2026 results showed COVID vaccine sales lifted revenue while a $0.9 billion litigation settlement widened GAAP loss and may shift positioning.